Scholarlink

Objectives <p>This study aimed to comprehensively examine coagulation parameters in patients with endometriosis versus those without to determine hematologic alterations associated with endometriosis.</p> Methods <p>Embase, PubMed, CINAHL, Web of Science, the Cochrane Library, CBM, CNKI, VIP, and Wanfang Database were searched through June 2024. The Newcastle-Ottawa Scale was used to evaluate the quality of the studies. Statistical analyses were performed using Stata 16.0 software.</p> Results <p>22 studies with 6,258 participants were included. The results showed significant abnormalities in coagulation parameters in patients with endometriosis compared to those without. Specifically, fibrinogen (FIB) (SMD = 0.57; 95%CI, 0.45 ~ 0.69; <i>P</i> &lt; 0.001), D-dimer (D-D) (SMD = 0.62; 95%CI, 0.27 ~ 0.96; <i>P</i> &lt; 0.001), and platelet count (PLT) (SMD = 0.28; 95%CI, 0.11 ~ 0.45; <i>P</i> = 0.001) were significantly elevated, while activated partial thromboplastin time (APTT) (SMD = -0.13; 95%CI, -0.22~-0.03; <i>P</i> = 0.010), prothrombin time (PT) (SMD = -0.31; 95%CI, -0.54~-0.08; <i>P</i> = 0.009), and thrombin time (TT) (SMD = -0.41; 95%CI, -0.63~-0.20; <i>P</i> &lt; 0.001) were significantly reduced.</p> <p>Moreover, FIB (SMD = 0.47; 95%CI, 0.23 ~ 0.71; <i>P</i> &lt; 0.001), D-D (SMD = 0.38; 95%CI, 0.10 ~ 0.66; <i>P</i> = 0.009), PT (SMD = -0.21; 95%CI, -0.41~-0.02; <i>P</i> = 0.030), and TT (SMD = -0.20; 95%CI, -0.38 ~ 0.01; <i>P</i> = 0.037) also vary between patients with stage I-II and stage III-IV endometriosis.</p> Conclusion <p>Multiple coagulation parameters were abnormal in endometriosis patients, indicating a hypercoagulable state, particularly pronounced in those with stage III-IV endometriosis. Large, globally representative prospective cohorts are needed to elucidate the causal relationship between endometriosis and hypercoagulability.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The abnormal coagulation status in endometriosis patients: a systematic review and meta-analysis

  • 期刊论文

  • 发表日期：

    2025年7月31日

查看全文
  • Xue Zeng,
  • Jinling Zhang,
  • Yijuan Peng,
  • Ke Zhuang,
  • Yan Huang

摘要

Objectives

This study aimed to comprehensively examine coagulation parameters in patients with endometriosis versus those without to determine hematologic alterations associated with endometriosis.

Methods

Embase, PubMed, CINAHL, Web of Science, the Cochrane Library, CBM, CNKI, VIP, and Wanfang Database were searched through June 2024. The Newcastle-Ottawa Scale was used to evaluate the quality of the studies. Statistical analyses were performed using Stata 16.0 software.

Results

22 studies with 6,258 participants were included. The results showed significant abnormalities in coagulation parameters in patients with endometriosis compared to those without. Specifically, fibrinogen (FIB) (SMD = 0.57; 95%CI, 0.45 ~ 0.69; P < 0.001), D-dimer (D-D) (SMD = 0.62; 95%CI, 0.27 ~ 0.96; P < 0.001), and platelet count (PLT) (SMD = 0.28; 95%CI, 0.11 ~ 0.45; P = 0.001) were significantly elevated, while activated partial thromboplastin time (APTT) (SMD = -0.13; 95%CI, -0.22~-0.03; P = 0.010), prothrombin time (PT) (SMD = -0.31; 95%CI, -0.54~-0.08; P = 0.009), and thrombin time (TT) (SMD = -0.41; 95%CI, -0.63~-0.20; P < 0.001) were significantly reduced.

Moreover, FIB (SMD = 0.47; 95%CI, 0.23 ~ 0.71; P < 0.001), D-D (SMD = 0.38; 95%CI, 0.10 ~ 0.66; P = 0.009), PT (SMD = -0.21; 95%CI, -0.41~-0.02; P = 0.030), and TT (SMD = -0.20; 95%CI, -0.38 ~ 0.01; P = 0.037) also vary between patients with stage I-II and stage III-IV endometriosis.

Conclusion

Multiple coagulation parameters were abnormal in endometriosis patients, indicating a hypercoagulable state, particularly pronounced in those with stage III-IV endometriosis. Large, globally representative prospective cohorts are needed to elucidate the causal relationship between endometriosis and hypercoagulability.